SMARCA4 and medulloblastoma: In other pediatric brain tumors, alterations in members of the SWI/SNF-complex are recurrently observed in medulloblastoma: SMARCA4 heterozygous missense variants have been identified in WNT activated and Group 3 tumors, where they cooperate with MYC to promote tumor formation and activate oncogenic transcription [8].